Navigation Links
EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program
Date:4/9/2008

MD-1198, a novel antimitotic agent, and ENMD-2076, a selective kinase inhibitor, are in Phase 1 studies in advanced cancers. The Company also has an approved IND application for Panzem(R) in rheumatoid arthritis. EntreMed's goal is to develop and commercialize new compounds based on the Company's expertise in angiogenesis, cell-cycle regulation and inflammation -- processes vital to the treatment of cancer and other diseases, such as rheumatoid arthritis. Additional information about EntreMed is available on the Company's web site at http://www.entremed.com and in various filings with the Securities and Exchange Commission.

Forward Looking Statements

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to the outlook for expectations for future financial or business performance (including the timing of royalty revenues and future R&D expenditures), strategies, expectations and goals. Forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Forward-looking statements speak only as of the date they are made, and no duty to update forward-looking statements is assumed. Actual results could differ materially from those currently anticipated due to a number of factors, including those set forth in Securities and Exchange Commission filings under "Risk Factors," including risks relating to the need for additional capital and the uncertainty of additional funding; variations in actual sales of Thalomid(R), risks associated with the Company's product candidates; the early-stage products under development; results in preclinical models are not necessarily indicative of clinical results, uncertainties relating to preclinical and clinical trials; success in the clinical development of any products; dependence on third parties; future capital needs; and risks relating to the commerci
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. EntreMed Commences Continuous Dosing Clinical Trial For MKC-1
2. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
3. EntreMed to Present at The New York Society of Security Analysts Industry Conference
4. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
5. EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model
6. EntreMed Reports Phase 1 PK and Preclinical Efficacy Results for ENMD-1198
7. EntreMed Raises $20 Million to Support Clinical Development Program
8. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
9. Bionomics Achieves US$1 Million Milestone Payment from Genmab
10. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
11. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... India , August 27, 2015 According ... Product (Transfer, Hammock, Toilet, Seating, Universal, Standing, Bariatric ), Material (Nylon, ... - Forecast to 2020", published by MarketsandMarkets, the Medical Lifting Sling ... USD 411.5 Million in 2015, at a CAGR of 11.4 % ... 136 ma rket data T ables and ...
(Date:8/27/2015)... -- MiMedx Group, Inc. (NASDAQ: MDXG ), the ... and patent-protected processes to develop and market advanced ... Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors ... inaccuracies in the press release issued by the ... from the Patent Trial and Appeal Board ("PTAB"). ...
(Date:8/27/2015)... According to a new market ... Standalone), by Deployment Mode (Web based, On-Premise, Cloud-Based), by ... Providers), by Component - Global Trends & Forecast to ... at $501.1 Million 2014, and is projected to reach ... from 2014 to 2019. Browse 60 ...
Breaking Medicine Technology:Medical Lifting Sling Market Worth USD 706.0 Million by 2020 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 4MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 2MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 3MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 4Radiology Information Systems Market Worth $722.7 Million by 2019 2Radiology Information Systems Market Worth $722.7 Million by 2019 3Radiology Information Systems Market Worth $722.7 Million by 2019 4
... CITY, Aug. 2, 2011 There is a company nestled ... Valley that is making strides in helping activate a usually ... Mind, creators of the eyeQ Speed Reading and Brain Enhancement ... Tech Pasadena and discovered astonishing results by measuring the difference ...
... Bio-Holdings, Ltd. - (OTCBB: HADSY), a publicly traded ... property developed and owned by Hadassah University Hospital, ... BioMarCare Technologies Ltd. ("BioMarCare") announced that the prestigious ... given initial approval for a $900,000 grant for ...
Cached Medicine Technology:Study Shows That Salt Lake City Based Company Has Program That Enhances Brain Activity 2BioMarCare Technologies Ltd. Receives a $900k Grant for a Joint Project with Ariadne Inc. 2BioMarCare Technologies Ltd. Receives a $900k Grant for a Joint Project with Ariadne Inc. 3
(Date:8/27/2015)... Los Angeles, CA (PRWEB) , ... August 27, 2015 , ... ... the most recent World Conference on Abdominal Wall Hernia Surgery involved many conversations between ... approved mesh options out there, the article notes that many different experts have different ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... exploding legal marijuana industry with the launch of its Doobster platform, a HIPAA-compliant ... to order products from their smart phones and tablets. Well, Doobster, “The ...
(Date:8/27/2015)... ... August 27, 2015 , ... Infocast is pleased to announce ... in San Jose, CA. The first event dedicated to finding alternative solutions ... exists where battery development and energy storage innovation are concerned. Product developers, ...
(Date:8/27/2015)... ... 2015 , ... In addition to its existing Doctor of Philosophy in Leadership ... at its main campus in Reading: Doctor of Nursing Practice. , Alvernia’s Doctor ... practice nurses for the highest level of clinical nursing practice. , “Our vision ...
(Date:8/27/2015)... ... August 27, 2015 , ... Florida Hospital North Pinellas, located at 1395 South Pinellas Avenue in ... 2016. The new facility will be located at US Highway 19 North and Highlands Boulevard, ... August 18, and work on the project is slated to begin in September 2015. ...
Breaking Medicine News(10 mins):Health News:Recent Article on Hernia Mesh Developments Highlights Viable Options, But Shows a Need for Further Research, notes Dr. Shirin Towfigh 2Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 2Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 3Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 4Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 5Health News:Infocast Hosting First Conference Dedicated to Powering Wearable Devices & the IoT 2Health News:Alvernia University Now Offering Three Doctoral Degree Programs 2Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 2Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 3
... The Mumbai-based Sun Pharmaceutical Industries entered the antismoking segment ... in Smoquit has been used for over a decade ... Rs. 13.50-per tablet priced Smoquit, the first pharmacotherapy ever ... prescription drug and is required to be taken under ...
... low testosterone levels in men suffering from eating ... affected more than women with the same problems, ... a weakening of the bones, which become dangerously thin ... and lack of essential nutrients, particularly calcium.Low bone mineral ...
... of proper nutrition while pregnant may be more likely to become ... from the University of Amsterdam looked at a group of 741 ... 1944-1945 which followed the Nazi occupation.// ,They found that ... when the study took place, was higher than in the general ...
... purple grape juice provides far greater antioxidant effects than ... journal of medicinal food. , The study states ... health through increased antioxidant consumption might prefer a glass ... juice," says Joe A. Vinson, professor of chemistry at ...
... men are at greater risk of developing heart disease than ... were published in the Archives of Internal Medicine, said they ... loss. ,The type of baldness also seemed to ... Those with frontal baldness had a 9% increased chance of ...
... supplement has been found to support immunity in elderly, ... every operation, rate of infection is a common risk, ... University of Pittsburgh report on the use of a ... undergoing surgery.// ,A group of 50 patients ...
Cached Medicine News:
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: